A Phase I Clinical And Pharmacokinetic Study Of SB939 In Patients With Advanced Cancer.
Phase of Trial: Phase I
Latest Information Update: 28 Mar 2016
At a glance
- Drugs Pracinostat (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 21 Jun 2011 Actual end date jun 2011 added as reported by ClinicalTrials.gov record.
- 21 Jun 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 19 Mar 2010 Status changed from suspended to active, no longer recruiting as reported by National Cancer Institute of Canada.